What does a high gross margin tell us about a company like Medifast in this comparison?

A high gross margin, such as Medifast's reported 72.44%, indicates the company retains a large portion of revenue after direct costs, suggesting strong pricing power or cost efficiency. However, margins can be affected by product mix, pricing strategies, and scale. In this comparison, the margin signals profitability potential even when other metrics are mixed, highlighting the difference between gross profitability and overall earnings.

How should we interpret a low price-to-book or price-to-sales ratio, as seen with HF Foods Group?

A low price-to-book (0.8x) and price-to-sales (0.2x) can imply the stock is undervalued relative to its accounting value and revenue. Yet this might reflect risks or limited growth visibility. For HF Foods Group, such multiples could attract value-focused investors, but they should be weighed against profitability, cash flow, and the market demand for its niche offerings.

Why is it important to compare a company’s current quarter performance with its longer-term trajectory?

Examining both quarterly results and longer-term trends helps identify whether a weakness is temporary or structural. In this page, Medifast’s Q3 2025 revenue decline contrasts with cost controls and margin resilience, while HF Foods’ valuation implies different growth expectations. Investors look for consistency, not single-period improvements, to gauge sustainability.

What does an analyst forecast upside of 80% for HF Foods Group imply in this comparison?

An 80% forecast upside suggests analysts expect meaningful rebound or growth for HF Foods Group. In context, it may reflect improving demand, expansion, or better margins. However, forecasts depend on assumptions and coverages, so they should be considered alongside profitability, cash flow, and competitive dynamics rather than as a guarantee.

How should the negative P/E for HF Foods influence risk assessment here?

A negative P/E indicates HF Foods Group is currently unprofitable on a trailing basis. This elevates investment risk and makes valuation less about earnings and more about cash flow, revenue growth and path to profitability. In this comparison, consider whether future profits are expected to materialise and at what pace.

How do market expectations shape the interpretation of Medifast’s operational shifts?

Market expectations respond to strategic pivots, such as Medifast moving from weight loss to metabolic health with a new product line. If investors anticipate successful execution, stock reaction can be positive even with near-term earnings pressure. Conversely, missed milestones can heighten concern, especially amid revenue volatility.

What market factors could influence demand for Medifast’s new product line in 2026?

Market factors include consumer health trends, competitive landscape in metabolic health products, pricing strategies, and retailer or direct-to-consumer reach. Adoption depends on perceived value, efficacy, and marketing. The scale of the product rollout will also affect revenue visibility and margin dynamics for Medifast.

What sector-specific risks should be considered for HF Foods Group’s niche market?

HF Foods Group operates in a specialised Asian foodservice market, which may face volatility from restaurant demand, input costs, and import regulations. Sector concentration can limit diversification and magnify exposure to restaurant chains’ health and spending cycles, impacting revenue stability and growth potential.

How should an investor approach reading these two companies’ metrics side by side?

Read side-by-side by focusing on revenue drivers, margins, profitability trajectory, and balance sheet strength. Note timing differences (quarterly results) and strategic actions (Medifast’s product launch, HF Foods’ valuation signals). Putting profitability, growth potential, and risk into context helps form a balanced view.

What is the purpose of including a neutral, educational disclaimer in this page?

The disclaimer clarifies that the analysis is educational and not financial advice. It encourages readers to perform their own research, consider their risk tolerance, and understand that figures can change with new information, ensuring readers interpret comparisons without assuming recommendations.

Medifast vs HF Foods

Medifast sells structured weight-loss programs and meal replacements; HF Foods distributes Asian food ingredients to restaurants across the United States. Medifast vs HF Foods pairs two consumer-linked businesses that couldn't look more different on the surface yet both live and die by repeat purchases and razor-thin distribution margins. Each faces its own headwinds: Medifast battles GLP-1 drug disruption while HF Foods navigates food-cost volatility and competitive distribution. Readers'll dig into how each company's recurring revenue model, customer retention, and balance sheet resilience stack up for long-term investors.

Medifast sells structured weight-loss programs and meal replacements; HF Foods distributes Asian food ingredients to restaurants across the United States. Medifast vs HF Foods pairs two consumer-linke...

Comparison Snapshot

Key Financial Metrics

MED

Metric

HFFG

$120.91M

Market Cap

$114.57M

50.00%

Potential Profit

N/A

Hold

Analyst Rating

N/A

Discover More Comparisons

Medifast vs TH International

Medifast distributes weight management and wellness products through its OPTAVIA coach-led community model, while TH International operates Tims China, the licensed Tim Hortons coffee chain in the Chinese market. Both are consumer brands scaling through network-driven growth strategies in their respective markets, and both have faced significant pressure on revenue and customer growth trajectories. Medifast vs TH International contrasts a U.S. direct-sales wellness company grappling with coach attrition against a foreign food and beverage brand building a retail footprint in one of the world's most competitive café markets.

Nature's Sunshine vs HF Foods

Nature's Sunshine Products sells herbal supplements and wellness products through a direct-sales network where independent consultants drive distribution, while HF Foods Group distributes Asian specialty meats, seafood, and produce to restaurants and foodservice operators across the United States. Nature's Sunshine vs HF Foods puts two small-cap consumer businesses with very specific niche distribution models under the same microscope, both exposed to shifting dietary preferences, supply chain disruptions, and the economics of reaching fragmented customer bases. Readers discover how direct-sales unit economics, consultant retention rates, and supplement margin profiles compare with foodservice distribution spreads and which company's customer loyalty dynamics produce a more predictable revenue trajectory.

Zevia vs HF Foods

Zevia sells zero-calorie, naturally sweetened beverages targeting health-conscious consumers in a market dominated by giants with massive distribution advantages, while HF Foods distributes Asian food products and ingredients to restaurants across the US. Both are small-cap consumer companies fighting for shelf space and customer loyalty against better-capitalized competitors. The Zevia vs HF Foods comparison examines revenue growth quality, margin trajectories, and what each company needs to prove to justify a growth premium.

Investment Analysis

Medifast

MED

Pros

Medifast has a strong gross margin of 72.44%, indicating good profitability on sales.
The company is repositioning from weight loss to metabolic health, launching a new product line in 2026, which could drive future growth.
Recent EPS surpassed forecast despite revenue decline, showing some cost control and earnings resilience.

Considerations

Q3 2025 revenue declined sharply by 36.2% year-over-year, reflecting significant operational challenges.
The number of active OPTAVIA coaches dropped 35% year-over-year, weakening the core sales channel.
Medifast reported a net loss of $2.3 million in Q3 2025, with the stock near its 52-week low, indicating market concerns.

HF Foods

HFFG

Pros

HF Foods Group serves a diverse product range including specialty foods, seafood, and fresh produce primarily to Asian restaurants in the US.
The company trades at a low price-to-book ratio of 0.8x and price-to-sales of 0.2x, implying potentially attractive valuation.
HF Foods has an analyst forecast upside of around 80%, suggesting market expectations for significant growth or recovery.

Considerations

The company has a negative P/E ratio of -4.1x, indicating it is currently unprofitable.
HF Foods Group operates in a niche Asian foodservice market which may limit broader growth opportunities and expose it to sector-specific risks.
Limited public financial disclosure and analyst coverage may increase uncertainty and investment risk.

Related Market Insights

The Future Of Food: Beyond Legacy Brands

Warren Buffett's Kraft Heinz writedown signals the decline of legacy food brands. Discover investment opportunities in innovative plant-based and healthy food companies disrupting the industry. Invest with Nemo.